Safety and Feasibility of Robot-Assisted Minimally Invasive Esophagectomy (RAMIE) with Three-Field Lymphadenectomy and Neoadjuvant Chemoradiotherapy in Patients with Resectable Esophageal Cancer and Cervical Lymph Node Metastasis.

Journal: Annals of surgical oncology
Published Date: Jan 27, 2023

Abstract

BACKGROUND: In the West, patients with cervical lymph node metastasis of resectable esophageal cancer at diagnosis are generally precluded from curative treatment. This study prospectively explored the safety and feasibility of neoadjuvant chemoradiotherapy followed by robot-assisted minimally invasive esophagectomy (RAMIE) with three-field lymphadenectomy for these patients.

Authors

  • S van der Horst
    Department of Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.
  • T J Weijs
    Department of Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.
  • W W Braunius
    Department of Head and Neck Surgical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • S Mook
    Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • N Haj Mohammed
    Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • L Brosens
    Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • P S N van Rossum
    Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • B L A M Weusten
    Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • J P Ruurda
    Department of Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.
  • R van Hillegersberg
    Department of Surgery, University Medical Center Utrecht, Utrecht, The Netherlands. r.vanhillegersberg@umcutrecht.nl.

Keywords

External Resources

Popular Topics
Recent Journals